A 72-year-old woman is brought to the emergency department due to severe, acute-onset shor… — USMLE Step 2 CK

A 72-year-old woman is brought to the emergency department due to severe, acute-onset shortness of breath. She has a history of essential hypertension, type 2 diabetes mellitus, severe obesity (BMI $44 \text{ kg/m}^2$ ), and a 40-pack-year smoking history.

On arrival, her blood pressure is $182/105 \text{ mmHg}$ , heart rate is $115\text{/min}$ , and respiratory rate is $28\text{/min}$ . Oxygen saturation is $86\%$ on room air.

Physical examination shows a patient in severe respiratory distress, using accessory muscles. Lung auscultation reveals diffuse expiratory wheezing with a markedly prolonged expiratory phase. No crackles are auscultated. Heart sounds are distant; no gallops are appreciated. Jugular venous pressure cannot be assessed due to body habitus.

Laboratory studies show a B-type natriuretic peptide (BNP) level of $210 \text{ pg/mL}$ (normal $<100 \text{ pg/mL}$ ).

Arterial blood gas analysis on room air shows:

Parameter	Value	Reference Range
pH	$7.48$	$7.35 - 7.45$
$PaCO_2$	$30 \text{ mmHg}$	$35 - 45 \text{ mmHg}$
$PaO_2$	$55 \text{ mmHg}$	$75 - 105 \text{ mmHg}$
$HCO_3^-$	$22 \text{ mEq/L}$	$22 - 28 \text{ mEq/L}$

A chest radiograph demonstrates hyperinflated lung fields, cardiomegaly, and prominent upper lobe vessels, without distinct alveolar infiltrates.

The patient receives sublingual nitroglycerin and intravenous furosemide, which leads to a dramatic resolution of her wheezing and dyspnea within one hour.

Which of the following best explains the relatively modest elevation of the B-type natriuretic peptide level in this patient despite the severity of her acute presentation?

Enhanced clearance by abundant natriuretic peptide clearance receptors in adipose tissueCevap
B
Reduced myocardial synthesis secondary to concentric left ventricular hypertrophy
C
The patient is primarily experiencing an acute exacerbation of chronic obstructive pulmonary disease
D
Right ventricular volume overload limits concurrent left ventricular peptide release
E
Rapid degradation of circulating peptides by upregulated pulmonary neprilysin

Cevap

Enhanced clearance by abundant natriuretic peptide clearance receptors in adipose tissue

The correct answer involves the physiological interaction between adipose tissue and natriuretic peptides. This patient's clinical picture—hypertension, hypoxia, respiratory alkalosis, and a rapid, positive response to nitroglycerin and furosemide—is classic for acute decompensated heart failure (ADHF). She is experiencing 'cardiac asthma', where pulmonary venous congestion causes peribronchial edema and wheezing, mimicking COPD. However, her B-type natriuretic peptide (BNP) level is only 210 pg/mL, which is surprisingly low for severe ADHF. This discrepancy is due to her severe obesity. Adipose tissue abundantly expresses the natriuretic peptide clearance receptor (NPR-C). The increased mass of adipocytes in obese individuals leads to accelerated removal of BNP from the circulation. Consequently, patients with severe obesity have significantly lower circulating BNP levels for any given degree of heart failure severity compared to non-obese patients, and lower diagnostic thresholds must be utilized.

Adım Adım Çözüm

Analyze the clinical presentation and treatment response.

The patient has severe dyspnea, wheezing, and hypertension, which rapidly improved with nitroglycerin and furosemide. This confirms a diagnosis of acute decompensated heart failure (ADHF) presenting as 'cardiac asthma'.

Differentiating ADHF from a COPD exacerbation is the critical first step. Diuretics and vasodilators treat ADHF but do not resolve a COPD exacerbation.

Interpret the arterial blood gas (ABG) findings.

The ABG shows acute primary respiratory alkalosis (pH 7.48, PaCO2 30 mmHg).

This further supports ADHF, as pulmonary edema stimulates J-receptors causing hyperventilation. Severe COPD exacerbations typically present with respiratory acidosis due to impaired ventilation.

Evaluate the BNP level in the context of the patient's demographics.

The BNP is 210 pg/mL, which is abnormally low for someone with severe ADHF.

The patient has severe obesity (BMI 44 kg/m^2). Adipocytes express large amounts of the natriuretic peptide clearance receptor (NPR-C), which removes BNP from the blood, artificially lowering the measured circulating levels.

Anahtar Kavram

B-type natriuretic peptide (BNP) levels are disproportionately lower in obese patients due to enhanced peptide clearance by abundant natriuretic peptide clearance receptors (NPR-C) expressed in adipose tissue.

Tahmini Süre:2m 0s

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru